High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis By Product (Synthetic, Biotech), Manufacturer (In-house, Outsourced), Drug Type, Therapeutic Application (Oncology, Hormonal, Glaucoma, Others), And Segment Forecasts, 2014 - 2025

Published: Jul, 2017 | Pages: 85 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. 

In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.

Further Key Findings From the Study Suggest: 

• Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules

• Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it

• Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment

• Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development

• Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs

• North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market

• Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth

• Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market

• The key players in the HPAPI market includeBristol-Myers Squibb,  Sigma-Aldrich Corporation, Pfizer Incand Lonza among others

• Extensive research and development activities carried out by market participants is also expected to augment the market growth

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Country wise market: Base estimates
                     1.1.1 Global market: CAGR calculation
                     1.1.2 Region based segment share calculation
                 1.2 Research Scope & Assumptions
                 1.3 List of Data Sources

Chapter 2 Executive Summary
                 2.1 Market Snapshot

Chapter 3 HPAPI Market Variables, Trends & Scope
                 3.1 Market segmentation & scope
                 3.2 Market Driver Analysis
                     3.2.1 Rise in prevalence of cancer and global anti-cancer market
                     3.2.2 Growth of Targeted Therapy Approach
                     3.2.3 Increasing application of HPAPI
                 3.3 Market Restraint Analysis
                     3.3.1 Large investments and very stringent safety and handling specifications associated with production of HPAPI
                 3.4 Key Opportunities Prioritized
                     3.4.1 Key opportunities prioritized, by product
                 3.5 HPAPI - SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.6 Industry Analysis - Porter's

Chapter 4 HPAPI Market: Product Estimates & Trend Analysis
                 4.1 HPAPI Market: Product Movement Analysis
                 4.2 Synthetic
                     4.2.1 Synthetic market, 2014 - 2025 (USD Million)
                 4.3 Biotech
                     4.3.1 Biotech market, 2014 - 2025 (USD Million)

Chapter 5 HPAPI Market: Manufacturer Estimates & Trend Analysis
                 5.1 HPAPI Market: Manufacturer Movement Analysis
                 5.2 In-house
                     5.2.1 In-house market, 2014 - 2025 (USD Million)
                 5.3 Outsourced
                     5.3.1 Outsourced market, 2014 - 2025 (USD Million)

Chapter 6 HPAPI Market: Drug Type Estimates & Trend Analysis
                 6.1 HPAPI Market: Drug Type Movement Analysis
                 6.2 Innovative
                     6.2.1 Innovative market, 2014 - 2025 (USD Million)
                 6.3 Generic
                     6.3.1 Generic market, 2014 - 2025 (USD Million)

Chapter 7 HPAPI Market: Therapeutic Application Estimates & Trend Analysis
                 7.1 HPAPI Market: Therapeutic Application Movement Analysis
                 7.2 Oncology
                     7.2.1 Oncology market, 2014 - 2025 (USD Million)
                 7.3 Hormonal
                     7.3.1 Hormonal market, 2014 - 2025 (USD Million)
                 7.4 Glaucoma
                     7.4.1 Glaucoma market, 2014 - 2025 (USD Million)
                 7.5 Others
                     7.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 8 HPAPI Market: Regional Estimates & Trend Analysis, by Product, Manufacturer, Drug Type, and Therapeutic Application
                 8.1 HPAPI Market Share by Region, 2016& 2025
                 8.2 North America
                     8.2.1 North America HPAPI market, by country, 2014 - 2025 (USD Million)
                     8.2.2 North America HPAPI market, by product, 2014 - 2025 (USD Million)
                     8.2.3 North America HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                     8.2.4 North America HPAPI market, by drug type, 2014 - 2025 (USD Million)
                     8.2.5 North America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.2.6 U.S.
                         8.2.6.1 U.S. HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.2.6.2 U.S. HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.2.6.3 U.S. HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.2.6.4 U.S. HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.2.7 Canada
                         8.2.7.1 Canada HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.2.7.2 Canada HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.2.7.3 Canada HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.2.7.4 Canada HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                 8.3 Europe
                     8.3.1 Europe HPAPI market, by country, 2014 - 2025 (USD Million)
                     8.3.2 Europe HPAPI market, by product, 2014 - 2025 (USD Million)
                     8.3.3 Europe HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                     8.3.4 Europe HPAPI market, by drug type, 2014 - 2025 (USD Million)
                     8.3.5 Europe HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.3.6 Germany
                         8.3.6.1 Germany HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.3.6.2 Germany HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.3.6.3 Germany HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.3.6.4 Germany HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.3.7 UK
                         8.3.7.1 UK HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.3.7.2 UK HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.3.7.3 UK HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.3.7.4 UK HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                 8.4 Asia Pacific
                     8.4.1 Asia Pacific HPAPI market, by country, 2014 - 2025 (USD Million)
                     8.4.2 Asia Pacific HPAPI market, by product, 2014 - 2025 (USD Million)
                     8.4.3 Asia Pacific HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                     8.4.4 Asia Pacific HPAPI market, by drug type, 2014 - 2025 (USD Million)
                     8.4.5 Asia Pacific HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.4.6 Japan
                         8.4.6.1 Japan HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.4.6.2 Japan HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.4.6.3 Japan HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.4.6.4 Japan HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.4.7 China
                         8.4.7.1 China HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.4.7.2 China HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.4.7.3 China HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.4.7.4 China HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.4.8 India
                         8.4.8.1 India HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.4.8.2 India HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.4.8.3 India HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.4.8.4 India HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                 8.5 Latin America
                     8.5.1 Latin America HPAPI market, by country, 2014 - 2025 (USD Million)
                     8.5.2 Latin America HPAPI market, by product, 2014 - 2025 (USD Million)
                     8.5.3 Latin America HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                     8.5.4 Latin America HPAPI market, by drug type, 2014 - 2025 (USD Million)
                     8.5.5 Latin America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.5.6 Brazil
                         8.5.6.1 Brazil HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.5.6.2 Brazil HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.5.6.3 Brazil HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.5.6.4 Brazil HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.5.7 Mexico
                         8.5.7.1 Mexico HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.5.7.2 Mexico HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.5.7.3 Mexico HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.5.7.4 Mexico HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                 8.6 MEA
                     8.6.1 MEA HPAPI market, by country, 2014 - 2025 (USD Million)
                     8.6.2 MEA HPAPI market, by product, 2014 - 2025 (USD Million)
                     8.6.3 MEA HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                     8.6.4 MEA HPAPI market, by drug type, 2014 - 2025 (USD Million)
                     8.6.5 MEA HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
                     8.6.6 South Africa
                         8.6.6.1 South Africa HPAPI market, by product, 2014 - 2025 (USD Million)
                         8.6.6.2 South Africa HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
                         8.6.6.3 South Africa HPAPI market, by drug type, 2014 - 2025 (USD Million)
                         8.6.6.4 South Africa HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
                 9.1 Strategy Framework
                 9.2 Market Participation
                 9.3 Company Profiles
                     9.3.1 Eli Lily and Company
                         9.3.1.1 Company overview
                         9.3.1.2 Financial performance
                         9.3.1.3 Product benchmarking
                         9.3.1.4 Strategic initiatives
                     9.3.2 Novartis AG
                         9.3.2.1 Company overview
                         9.3.2.2 Financial performance
                         9.3.2.3 Product benchmarking
                         9.3.2.4 Strategic initiatives
                     9.3.3 Bristol-Myers Squibb Company
                         9.3.3.1 Company overview
                         9.3.3.2 Financial performance
                         9.3.3.3 Product benchmarking
                         9.3.3.4 Strategic initiatives
                     9.3.4 Roche Diagnostics Ltd.
                         9.3.4.1 Company overview
                         9.3.4.2 Financial performance
                         9.3.4.3 Product benchmarking
                         9.3.4.4 Strategic initiatives
                     9.3.5 Sanofi
                         9.3.5.1 Company overview
                         9.3.5.2 Financial performance
                         9.3.5.3 Product benchmarking
                         9.3.5.4 Strategic initiatives
                     9.3.6 Hospira, Inc.
                         9.3.6.1 Company overview
                         9.3.6.2 Financial performance
                         9.3.6.3 Product benchmarking
                         9.3.6.4 Strategic initiatives
                     9.3.7 BASF SE
                         9.3.7.1 Company overview
                         9.3.7.2 Financial performance
                         9.3.7.3 Product benchmarking
                         9.3.7.4 Strategic initiatives
                     9.3.8 Covidien plc
                         9.3.8.1 Company overview
                         9.3.8.2 Financial performance
                         9.3.8.3 Product benchmarking
                         9.3.8.4 Strategic initiatives
                     9.3.9 Boehringer Ingelheim GmbH
                         9.3.9.1 Company overview
                         9.3.9.2 Financial performance
                         9.3.9.3 Product benchmarking
                         9.3.9.4 Strategic initiatives
                     9.3.10 Merck & Co., Inc.
                         9.3.10.1 Company overview
                         9.3.10.2 Financial performance
                         9.3.10.3 Product benchmarking
                         9.3.10.4 Strategic initiatives
                     9.3.11 Sigma Aldrich Corporation
                         9.3.11.1 Company overview
                         9.3.11.2 Financial performance
                         9.3.11.3 Product benchmarking
                         9.3.11.4 Strategic initiatives
                     9.3.12 Bayer AG
                         9.3.12.1 Company overview
                         9.3.12.2 Financial performance
                         9.3.12.3 Product benchmarking
                         9.3.12.4 Strategic initiatives
                     9.3.13 Carbogen Amcis AG
                         9.3.13.1 Company overview
                         9.3.13.2 Financial performance
                         9.3.13.3 Product benchmarking
                         9.3.13.4 Strategic initiatives
                     9.3.14 Lonza
                         9.3.14.1 Company overview
                         9.3.14.2 Financial performance
                         9.3.14.3 Product benchmarking
                         9.3.14.4 Strategic initiatives
                     9.3.15 Teva Pharmaceutical Industries Ltd.
                         9.3.15.1 Company overview
                         9.3.15.2 Financial performance
                         9.3.15.3 Product benchmarking
                         9.3.15.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America HPAPI market, by country, 2014 - 2025 (USD Million)
TABLE 3 North America HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 4 North America HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 5 North America HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 6 North America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 7 U.S. HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 8 U.S. HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 9 U.S. HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 10 U.S. HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 11 Canada HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 12 Canada HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 13 Canada HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 14 Canada HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 15 Europe HPAPI market, by country, 2014 - 2025 (USD Million)
TABLE 16 Europe HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 17 Europe HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 18 Europe HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 19 Europe HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 20 Germany HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 21 Germany HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 22 Germany HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 23 Germany HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 24 UK HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 25 UK HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 26 UK HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 27 UK HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific HPAPI market, by country, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 30 Asia Pacific HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 31 Asia Pacific HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 32 Asia Pacific HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 33 JapanHPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 34 JapanHPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 35 JapanHPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 36 Japan HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 37 China HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 38 China HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 39 China HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 40 China HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 41 India HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 42 India HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 43 India HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 44 India HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 45 Latin America HPAPI market, by country, 2014 - 2025 (USD Million)
TABLE 46 Latin America HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 47 Latin America HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 48 Latin America HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 49 Latin America HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 50 Brazil HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 51 Brazil HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 52 Brazil HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 53 Brazil HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 54 Mexico HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 55 Mexico HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 56 Mexico HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 57 Mexico HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 58 MEA HPAPI market, by country, 2014 - 2025 (USD Million)
TABLE 59 MEA HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 60 MEA HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 61 MEA HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 62 MEA research drug types market, by type, 2014 - 2025 (USD Million)
TABLE 63 MEA HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)
TABLE 64 South Africa HPAPI market, by product, 2014 - 2025 (USD Million)
TABLE 65 South Africa HPAPI market, by manufacturer, 2014 - 2025 (USD Million)
TABLE 66 South Africa HPAPI market, by drug type, 2014 - 2025 (USD Million)
TABLE 67 South Africa HPAPI market, by therapeutic application, 2014 - 2025 (USD Million)